We are live on ! Find out more
VP

Vitruvian Partners Portfolio holdings

AUM $112M
1-Year Est. Return 2.02%
This Fund
S&P 500
This Quarter Est. Return
-12.05%
1 Year Est. Return
+2.02%
3 Year Est. Return
+35.84%
5 Year Est. Return
+18.92%
10 Year Est. Return
AUM
$475M
AUM Growth
-$85.4M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
9
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 53.05%
2 Technology 37.23%
3 Healthcare 5.91%
4 Industrials 3.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLBE icon
1
Global E Online
GLBE
$6.4B
$234M 49.32%
11,349,685
WKME
2
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
$66.2M 13.94%
5,921,122
MQ icon
3
Marqeta
MQ
$1.84B
$65.8M 13.85%
2,691,546
AYX
4
DELISTED
Alteryx Inc
AYX
$41.5M 8.74%
819,547
MXCT icon
5
MaxCyte
MXCT
$133M
$27.5M 5.8%
5,043,356
FTCH
6
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$18.1M 3.81%
3,829,474
CARG icon
7
CarGurus
CARG
$3.16B
$17.7M 3.72%
1,261,219
API
8
Agora
API
$331M
$3.3M 0.69%
844,105
GLS
9
DELISTED
Gelesis Holdings, Inc.
GLS
$545K 0.11%
1,876,106

Similar funds

Vitruvian Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Vitruvian Partners held 9 positions worth $475M, down 15% from $560M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 0%. Vitruvian Partners opened no new positions and made no exits, leaving the 9-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Discretionary at 53% of assets, down from 57% a quarter earlier, followed by Technology and Healthcare.

  • Vitruvian Partners's ten largest holdings make up 100% of its $475M portfolio in Q4 2022.
  • Vitruvian Partners opened 0 new positions and closed 0 in Q4 2022.
  • Vitruvian Partners's portfolio value fell 15% quarter-over-quarter to $475M.

Based on Vitruvian Partners's 13F filing for Q4 2022, filed 11 Jan 2023.